Distinct Biological Patterns in Major Depressive Disorder Identified

Strategic Insights -

Major depressive disorder (MDD) with suspected non-Alzheimer's disease pathophysiology (SNAP) and MDD without SNAP exhibit distinct biological patterns, according to a new study. Researchers conducted cross-sectional analyses of 136 MDD patients, classified into SNAP and non-SNAP groups, and found significant associations among cerebral amyloid-b deposition, glucose metabolism, and hippocampal volume in both groups. However, the biological profiles differed between the two groups, with greater amyloid deposition associated with reduced glucose metabolism and smaller hippocampal volume in non-SNAP MDD, and lower amyloid deposition associated with lower glucose metabolism in SNAP MDD.

Key Takeaways:

  • The study identified distinct biological patterns in MDD patients with and without suspected non-Alzheimer's disease pathophysiology (SNAP).
  • In the non-SNAP MDD group, greater amyloid deposition was associated with reduced glucose metabolism and smaller hippocampal volume.
  • In the SNAP MDD group, lower amyloid deposition was associated with lower glucose metabolism.
  • The study found that hippocampal atrophy and cognition function were negatively correlated with amyloid deposition in non-SNAP MDD, but positively correlated with amyloid deposition in SNAP MDD.
  • The research highlights the need for subgroup-specific approaches to better elucidate the pathophysiology of MDD.
  • Authors Ing-Tsung Hsiao, Min-Jung Wu, Kun-Ju Lin, Yi-Ming Wu, and Kuan-Yi Wu conducted the research at Chang Gung Memorial Hospital.

Statistics:

  • 136 MDD patients were enrolled in the study.
  • 71 patients were classified as SNAP, while 65 were classified as non-SNAP.
  • The study used dual-phase F-florbetapir (AV45) PET/MR scans to image amyloid deposition and glucose metabolism.
  • Hippocampal volume was measured using MRI, with bilaterally adjusted hippocampal volume (HVa) showing a positive correlation with glucose metabolism in non-SNAP MDD.
  • In non-SNAP MDD, greater amyloid deposition was associated with 24.1% reduced glucose metabolism and 15.6% smaller hippocampal volume.

Sources:

  • NewsRx. Researchers from Chang Gung Memorial Hospital Provide Details of New Studies and Findings in the Area of Alzheimer Disease [Cerebral amyloid-b, glucose metabolism and hippocampal volume in major depression with and without suspected ...]. Mental Health Weekly Digest. October 13, 2025; p 966.
  • Hsiao, I., Wu, M., Lin, K., Wu, Y., & Wu, K. (2025). Cerebral amyloid-b, glucose metabolism and hippocampal volume in major depression with and without suspected non-Alzheimer pathophysiology (SNAP). Alzheimer's Research & Therapy, 17(1), 207.